Business Context and Reporting Period
Company: PRO DEX INC (PDEX)
Filing Type: Form 10-K (Annual Report)
Period Ended: June 30, 2009
Business Overview: Pro-Dex designs, develops, and manufactures rotary drive systems, motion control software/hardware, and fractional horsepower DC motors. Primary markets include medical devices, dental, aerospace, military, and industrial applications. Operations are located in Irvine, CA; Beaverton, OR; and Carson City, NV.
Key Financial Metrics
| Metric ($ in thousands) | Fiscal 2009 | Fiscal 2008 |
|---|---|---|
| Net Sales | $21,122 | $25,126 |
| Gross Profit | $6,748 | $8,209 |
| Gross Margin | 32% | 33% |
| Operating Income (Loss) | $(1,492) | $456 |
| Net Income (Loss) | $(2,845) | $317 |
| EPS (Basic) | $(0.29) | $0.03 |
| Cash and Cash Equivalents | $1,124 | $517 |
| Net Debt | $2,200 (approx) | $3,500 (approx) |
| Operating Cash Flow | $1,718 | $2,018 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 16% ($4.0 million) to $21.1 million. Medical sales dropped 21% due to lower shipments to top customers following inventory builds in the prior year. Industrial sales fell 25% due to a slowdown in motion control orders. Aerospace sales increased 10%.
- Profitability Reversal: The company swung from a net income of $317,000 in 2008 to a net loss of $2.8 million in 2009.
- Non-Cash Charges: The loss was significantly impacted by two major non-cash charges:
- Intangible Impairment: A $997,000 charge related to the write-down of the "Intraflow" patent asset due to the inability to find a distribution partner.
- Tax Valuation Allowance: A $2.2 million charge establishing a valuation allowance against deferred tax assets due to cumulative losses.
- Cost Reductions: Headcount was reduced by 10% (from 145 to 127 employees). Warranty costs decreased by over 50% to $664,000.
Guidance, Outlook, Risks, and Contingencies
- Outlook: Management anticipates a return to profitability as the economy strengthens. The company has a lower cost structure, improved legacy product performance, and two major product launches in the pipeline. Backlog remains relatively stable at $9.8 million.
- Delisting Risk: The company's stock price has remained below $1.00, triggering a Nasdaq delisting deadline of January 7, 2010. Shareholders have authorized a reverse stock split to potentially avoid delisting.
- Credit Facility Covenants: The company violated profitability and cash flow covenants with Wells Fargo and Union Bank in 2009. Waivers were obtained, but the Wells Fargo line of credit was reduced from $4 million to $1 million. As of September 2009, no un-waived violations remained.
- Legal Contingency: Pro-Dex is a defendant in a groundwater contamination lawsuit filed by the Orange County Water District regarding a former Santa Ana site. Liability is uncertain, but defense costs are largely covered by past insurance policies.
Investor Verification Checklist
- Delisting Status: Verify if the reverse stock split was executed or if the stock price recovered to meet Nasdaq minimum bid requirements by the January 2010 deadline.
- Customer Concentration: Confirm the stability of the top two customers, who accounted for 60% of sales in 2009 (one customer alone was >31%).
- Credit Facility Terms: Review the current status of the Wells Fargo and Union Bank credit lines and any ongoing covenant compliance requirements.
- Intangible Asset Value: Assess the remaining value of the Intraflow patent ($147,000 carrying value) and the likelihood of finding a distribution partner.
- Deferred Tax Assets: Monitor future profitability to determine if the $2.2 million valuation allowance can be reversed in future periods.